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Abstract
Gain-of-function mutations in KCNJ2-encoded Kir2.1 channels underlie variant 3 (SQT3) of
the short QT syndrome, which is associated with atrial fibrillation (AF). Using biophysically-
detailed human atria computer models, this study investigated the mechanistic link between
SQT3 mutations and atrial arrhythmogenesis, and potential ion channel targets for treat-
ment of SQT3. A contemporary model of the human atrial action potential (AP) was modified
to recapitulate functional changes in IK1 due to heterozygous and homozygous forms of the
D172N and E299V Kir2.1 mutations. Wild-type (WT) and mutant formulations were incorpo-
rated into multi-scale homogeneous and heterogeneous tissue models. Effects of mutations
on AP duration (APD), conduction velocity (CV), effective refractory period (ERP), tissue
excitation threshold and their rate-dependence, as well as the wavelength of re-entry (WL)
were quantified. The D172N and E299V Kir2.1 mutations produced distinct effects on IK1
and APD shortening. Both mutations decreased WL for re-entry through a reduction in ERP
and CV. Stability of re-entrant excitation waves in 2D and 3D tissue models was mediated
by changes to tissue excitability and dispersion of APD in mutation conditions. Combined
block of IK1 and IKr was effective in terminating re-entry associated with heterozygous
D172N conditions, whereas IKr block alone may be a safer alternative for the E299V muta-
tion. Combined inhibition of IKr and IKur produced a synergistic anti-arrhythmic effect in both
forms of SQT3. In conclusion, this study provides mechanistic insights into atrial proarrhyth-
mia with SQT3 Kir2.1 mutations and highlights possible pharmacological strategies for man-
agement of SQT3-linked AF.
Author summary
Atrial fibrillation (AF) is the most common cardiac arrhythmia, and is characterised by
complex and irregular electrical activation of the upper chambers of the heart. One rare,
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genetic condition associated with increased risk of AF is the short QT syndrome (SQTS),
which is caused by mutations in genes involved in normal electrical function of the heart.
Underlying mechanisms by which SQTS-related gene mutations facilitate development of
arrhythmias in the human atria are not well understood. In this study, sophisticated com-
puter models representing ‘virtual’ human atria, incorporating detailed electrophysiologi-
cal data at the ‘ion channel’ protein level into both idealised and realistic multi-scale tissue
geometries, were used to dissect mechanisms by which two mutations in the KCNJ2 gene
responsible for SQTS variant 3 (SQT3) promote initiation and sustenance of arrhythmias.
It was found that the D172N and E299V mutations to KCNJ2 accelerated the repolarisa-
tion process at the cellular level through distinct mechanisms. This, along with the way
the mutations affected heterogeneity in electrical behaviour at the organ level, mediated
stability of arrhythmias and response to simulated ion channel block. This study improves
understanding of mechanisms underlying increased AF risk associated with D172N and
E299V KCNJ2 mutations, and outlines potential therapeutic strategies.
Introduction
The cardiac inward rectifier potassium current (IK1) is responsible for stabilising the resting
membrane potential (RMP) and contributes to terminal repolarisation of both atrial and ven-
tricular action potentials (APs) [1]. The K+ channels that mediate IK1 are comprised of Kir2.x
family of subunits, of which the KCNJ2-encoded Kir2.1 is strongly expressed in both the atria
and ventricles [2]. Loss-of-function of Kir2.1 channels has been implicated in the Andersen-
Tawil syndrome (long QT syndrome type 7) and causes ventricular arrhythmias and a range of
extracardiac abnormalities [3]. Gain-of-function KCNJ2 mutations are also potentially life-
threatening, underlying variant 3 of the short QT syndrome (SQT3) [4–6], as well as familial
atrial fibrillation (AF) [7].
The short QT syndrome (SQTS) is a genetic disorder that has been associated with in-
creased risk of ventricular and atrial arrhythmias, and of sudden cardiac death [8,9]. The
SQTS phenotype is characterised by an abbreviated QT interval, tall and peaked T waves,
and loss of rate-adaptation of the QT interval [9]. To date, four missense mutations have been
identified in KCNJ2-linked short QT syndrome (SQT3): D172N [4], M301K [5], E299V [6],
and K346T [10], with reports of AF in some patients [5,6]. The first reported SQT3 mutation,
D172N Kir2.1 [4], was shown to increase significantly outward IK1 at potentials between −75
mV and −45 mV. The proband and her father exhibited significantly shortened QTc intervals
(315 ms and 320 ms, respectively) and presented with a history of presyncopal events and pal-
pitations [4]. The subsequently discovered E299V Kir2.1 mutation was shown to differ from
D172N in that it strongly affects inward rectification, resulting in large outward IK1 currents at
potentials above −55mV [6]. The proband presented with an extremely short QT interval (200
ms) which showed no rate-adaptation, and recurring episodes of paroxysmal AF [6].
A link between increased IK1 and acquired AF is well-established, with upregulation of IK1
consistently observed in chronic AF-induced electrical remodelling of the human atrial action
potential (AP) [11–14]. Previously it has been shown that increased IK1 shortened the action
potential duration (APD) and stabilised rotors in computational models of human atrial
electrophysiology [15–18]. Increased IK1 arising from the E299V Kir2.1 mutation has also
been shown to be pro-arrhythmic at cellular and 2D tissue levels [6]. However, the atria are
characterised by marked electrical heterogeneity [19–22], which has been shown previously to
generate an arrhythmia substrate in silico [23,24]. Mechanisms underlying initiation and
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maintenance of atrial arrhythmias at cellular and organ levels arising from interactions
between genetic mutations and intrinsic electrical heterogeneities in human atria have yet to
be investigated using anatomically-detailed, 3D phenotypically-accurate models of SQT3
mutant IK1.
Furthermore, possible similarities and/or differences in the atrial pro-arrhythmic mecha-
nisms of Kir2.1 mutations due to their distinct effects on IK1 in the SQTS have not yet been
characterised. The D172N and E299V mutations have distinct effects on currents carried by
Kir2.1 channels; the D172 residue is involved in the steep, highly voltage-dependent portion of
rectification [4,25,26], whereas E299 is involved in the shallow part of rectification which
shows less voltage dependence [6,27]. The effects of the E299V mutation on Kir2.1 currents
are more pervasive than are those of Kir2.1 D172N, as the E299V mutation significantly alters
the membrane potential range over which IK1 is active, fundamentally changing its role in
repolarisation of the AP. The comparative pro-arrhythmic effects of these two distinct muta-
tions have yet to be elucidated.
This study aimed to evaluate and compare the influence of the SQT3 D172N and E299V
Kir2.1 mutations on atrial repolarisation and susceptibility to re-entrant excitation, using het-
erogeneous, multi-scale models of human atrial electrophysiology. It also aimed to investigate
the effects of simulated ion channel inhibition on SQT3-mediated AF, as this may provide the-
oretical insights into possible pharmacological approaches for the management of AF in
SQT3.
Results
Model validation
IK1 formulations developed in wild-type (WT) and SQT3 mutant conditions accurately repro-
duced experimental I-V relationship data under voltage clamp conditions; namely (i) signifi-
cantly increased outward currents at potentials in the range of −75 to −45 mV in D172N
mutation conditions, and (ii) impaired inward rectification and increased outward IK1 at
potentials above −55 mV associated with the E299V mutation, as shown in Fig 1. Furthermore,
simulated AP clamps using the same digitised human atrial AP waveform as employed in pre-
vious in vitro experiments showed strong agreement with those obtained experimentally in
WT and D172N conditions [26]. The Colman et al. (CZ) human atrial cell model updated with
our WT IK1 formulation gave AP characteristics which were in excellent agreement with
experimental data from human atrial myocytes (Supplemental S1 and S2 Figs). Incorporation
of the modified family of CZ regional cell models into our 3D human atria geometry, as shown
in Fig 2, gave a total activation time (AT) and conduction velocity (CV) in good agreement
with experimental measurements (total AT 122 ms versus 116 ± 18 ms [28]; CV 0.71 ms−1 in
the RA versus 0.7–0.9 ms−1 in RA free wall [29]).
Effects of SQT3 mutant IK1 on single cell atrial APs
Alterations to IK1 due to SQT3 mutations accelerated the repolarisation phase of action poten-
tials in all conditions investigated, as shown in Fig 3A. The D172N mutation resulted in short-
ening of APD90 and hyperpolarisation of the resting membrane potential (RMP) (Fig 3Ai),
with the homozygous condition exerting a more profound effect than the heterozygous condi-
tion. This was associated with an increased outward IK1 without altered rectification (see Fig
1A), providing a stronger repolarising current during terminal repolarisation (Fig 3Aii). In
contrast, as the E299V mutation markedly altered (WT-E299V) or abolished (E299V) inward
rectification of IK1 over the physiological range of membrane potentials (see Fig 1B), it resulted
in a significant contribution of outward IK1 during the entire AP, suppressing the AP plateau
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and uniformly shortening the APD (Fig 3Ai and 3Aii). A summary of the effects of the studied
mutations on AP characteristics at a pacing frequency of 1 Hz is shown in Table 1.
Fig 3 also shows secondary effects of mutant IK1 on ICaL (Fig 3Aiii) and INa (Fig 3Aiv). The
D172N mutation conditions affected the AP during terminal repolarisation; at this phase of
the AP little inward current is passed through the L-type calcium channel, thus the profile of
ICaL was not significantly affected. The E299V mutation conditions, which reduced or abol-
ished inward rectification of IK1 over physiological voltages, caused a decreased plateau poten-
tial of the AP, reducing ICaL during this phase. The effect of mutations on the RMP altered the
profile of INa in two ways; (i) hyperpolarised RMP as seen in the D172N conditions increased
sodium current availability thus increasing peak current density, and (ii) time for activation of
INa following stimulation increased as a function of the voltage difference between the RMP
and threshold potential for AP initiation (or decreased in the case of the homozygous E299V
mutation which was associated with more depolarised RMP). Whereas the WT-E299V muta-
tion did not significantly affect the RMP, the homozygous E299V mutation condition led to a
small depolarisation of the RMP, due to decreased outward currents in the region of ~70–80
mV. Elevation of the RMP, as seen for the E299V mutation, resulted in partial inactivation of
sodium channels, decreasing INa amplitude (Fig 3Aiv), the action potential amplitude (APA)
and maximum upstroke velocity (MUV) (see Table 1).
All mutation conditions investigated shortened the APD90 across a wide range of diastolic
intervals (DIs) (Fig 3Bi). The maximal slope of APD restitution (Fig 3Bii) was decreased in all
Fig 1. Experimental and simulated I-V and gK1-V relationships. Comparison of model I-V relationship
(Ai) and computed gK1-V relationship (Aii) in WT, WT-D172N, and D172N conditions (solid lines) with the
experimental data of El Harchi et al. [26] (points). Simulated AP clamps using a digitised AP waveform from
the Nygren et al. human atrial cell model [30] as described in [26] are shown inset. Comparison of model I-V
relationship (Bi) and computed gK1-V relationship (Bii) in WT, WT-E299V, and E299V conditions (solid lines)
with the experimental data of Deo et al. [6] (points). The voltage clamp protocol used in each case is shown
inset in (i).
https://doi.org/10.1371/journal.pcbi.1005593.g001
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SQT3 mutation conditions compared to the WT, with the homozygous E299V mutation in
particular showing almost no rate adaptation. Whereas the APD measured in the homozygous
D172N condition was longer than that in both heterozygous and homozygous E299V muta-
tions at normal pacing rates, at fast pacing rates the homozygous D172N restitution curve
crossed over the E299V curves.
Effects of SQT3 mutant IK1 on tissue APD distribution
Each regional cell model incorporated into the 3D virtual human atria has a different AP pro-
file due to intrinsic different electrophysiological properties of the atria [19,22,31]. The spatial
distribution of the action potential duration, ΔAPD, in coupled tissue is influenced by electro-
tonic coupling, with regional APD depending on region size and the APD of neighbouring
regions. ΔAPD across the 3D human atria geometry at a pacing frequency of 1 Hz for all muta-
tions is shown in Fig 4. The D172N mutation conditions showed only a modest decrease in
global ΔAPD, whilst increasing APD heterogeneity at the CT/PM junction and preserving a
high degree of heterogeneity at the PV/LA junction (summarised in S3 Fig). The E299V muta-
tion conditions, however, caused a more marked decrease in ΔAPD, with the homozygous
E299V mutant showing the most homogenous APD distribution (overall ΔAPD of 69 ms ver-
sus 120 ms in the WT case). Whereas ΔAPD at the CT/PM junction was increased for the
Fig 2. 3D anatomical atria model and regional APs. The anatomical atria geometry shown from two views–looking
at the RA posterior wall and into the cavities (A), with regions of atrial septum (AS), atrio-ventricular ring (AVR), crista
terminalis (CT), left atrium (LA), left atrial appendage (LAA), left pulmonary veins (LPV), pectinate muscles (PM), right
atrium (RA), right atrial appendage (RAA), right pulmonary veins (RPV), and sinoatrial node (SAN) shown for reference.
Action potentials for regional cell models including the Bachmann’s bundle (BB) at 1 Hz (B), with colours corresponding
to tissue segmentation in (A). Activation sequence in the heterogeneous 3D anatomical atria model, following initiation
of an AP in the SAN region (C).
https://doi.org/10.1371/journal.pcbi.1005593.g002
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E299V mutation conditions, there was almost no difference in APD at the PV/LA junction for
the WT-E299V condition, and APs failed to propagate uniformly across the PV region in the
E299V condition (conduction blocks shown in black). This was due to the combination of
reduced CV and increased electrotonic suppression arising from differences in RMP from the
Fig 3. Simulated AP profiles and current traces in WT and mutation conditions. Action potential profiles
in WT (blue), WT-D172N (mauve), D172N (red), WT-E299V (orange), and E299V (green) conditions at a
pacing frequency of 1 Hz (Ai), with inset showing RMP. Corresponding current traces are shown for IK1 (Aii),
ICaL (Aiii), and INa (Aiv). Insets for panels (Aii) and (Aiv) show current profiles during the AP upstroke for IK1
and INa, respectively. (Bi) Restitution of the APD90 as determined using an S1-S2 protocol, and (Bii) maximal
slope of restitution.
https://doi.org/10.1371/journal.pcbi.1005593.g003
Table 1. AP properties in WT and SQT3 mutant conditions in the baseline single cell model.
APA (mV) RMP (mV) APD50 (ms) APD90 (ms) MUV (V/s)
WT 99.2 -75.0 171.6 259.9 194.5
WT-D172N 103.0 -78.6 166.6 213.9 214.4
D172N 103.5 -79.9 154.7 177.5 200.5
WT-E299V 99.8 -75.8 99.4 154.4 199.4
E299V 94.5 -73.0 60.4 125.0 173.1
A summary of atrial AP characteristics: action potential amplitude (APA), resting membrane potential (RMP), action potential duration at 50% and 90%
repolarisation (APD50 and APD90, respectively), and maximum upstroke velocity (MUV) in the baseline single cell model at a pacing frequency of 1 Hz.
https://doi.org/10.1371/journal.pcbi.1005593.t001
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surrounding LA region. Augmented regional differences at the CT/PM junction led to an
increase in the temporal vulnerability to uni-directional conduction block in all mutation con-
ditions (see S4 Fig).
Effects of SQT3 mutant IK1 on tissue restitution properties
Restitution curves for the conduction velocity (CV), effective refractory period (ERP), wave-
length (WL) of re-entry, and tissue excitability measured in the 1D strand are shown in Fig 5.
Alterations to CV restitution (Fig 5A) were mediated primarily by effects of the mutations on
Fig 4. Spatial dispersion of APD in 3D anatomical atria model. APD distribution maps in WT (A), WT-D172N (B), D172N (C), WT-E299V (D),
and E299V (E) mutation conditions, with corresponding global ΔAPD (F). The colour bar shows APD relative to the shortest APD measured in
each condition, designated APD+. The scale of the colour bar is fixed at the value of ΔAPD in the WT condition (120 ms) to facilitate comparison
between the mutation conditions. The colour black shows regions where membrane potentials failed to exceed a threshold value (−20 mV).
https://doi.org/10.1371/journal.pcbi.1005593.g004
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the RMP. The D172N mutation conditions hyperpolarised the RMP; this resulted in increased
sodium channel availability, outweighing any antagonistic effect of increased outward IK1 dur-
ing membrane depolarisation and increasing single cell MUV (see Table 1) which might be
expected to lead to an increase in CV. However, the increased voltage gradient between active
and resting cells in tissue resulted in higher electrotonic suppression at the wavefront, causing
an overall decrease in conduction velocity. The CV in the WT-E299V condition was decreased
by similar mechanisms. For the homozygous E299V mutation condition, the voltage gradient
between active and resting cells was reduced, yet the combination of depolarised RMP (which
decreases sodium channel availability) and increased outward currents during membrane
depolarisation led to a more significant reduction in CV than for the heterozygous mutant
form.
The ERP was shortened in all mutation conditions compared to the WT, with the homozy-
gous E299V condition showing the least rate adaptation (Fig 5B). ERP restitution in the E299V
and WT-E299V mutation conditions showed a deflection to higher values at fast rates, with
minima at basic cycle lengths (BCL) of ~270 ms and ~200 ms, respectively. As with the single
Fig 5. Tissue restitution properties in WT and mutation conditions. Restitution of the CV (A), ERP (B), and WL of re-entry (C) against a
range of basic cycle lengths (BCL), and excitation threshold (D) against a range of S1-S2 stimulus intervals (SI), as measured in the 1D
tissue model.
https://doi.org/10.1371/journal.pcbi.1005593.g005
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cell APD restitution, the D172N ERP restitution curve crossed those of the E299V mutation
conditions at fast rates. The WL of re-entry was shortened for all SQT3 mutants across the
range of DIs investigated (Fig 5C). AP alternans arising from fast rate pacing were reduced in
all mutation conditions, consistent with a decrease in the steepness of restitution.
The rate-dependent effect of the SQT3 mutations on tissue excitability, measured as exci-
tation threshold, is shown in Fig 5D. At low rates the D172N mutation conditions decreased
tissue excitability, the WT-E299V mutation did not significantly affect excitability, and the
homozygous E299V mutation increased excitability. At high rates, all mutations investigated
increased excitability compared to the WT. For example, at a stimulus interval (SI) of 300 ms
the excitation threshold for the WT tissue was 169 pA/pF compared with 41 pA/pF for WT-
D172N, 45 pA/pF for D172N, 37 pA/pF for WT-E299V, and 34 pA/pF for E299V mutant tis-
sue. Differences in excitation threshold between mutation conditions can be explained by how
the mutations affected the RMP, i.e. mutations which hyperpolarised the RMP increased the
voltage gradient between the RMP and the threshold for AP firing, thus larger stimulus cur-
rents were required to elicit APs which propagate in tissue. The SI at which the excitation
threshold began to tend towards an infinite value is determined by the degree of APD shorten-
ing in each of the mutation conditions.
Characterisation of spiral wave dynamics in 2D due to SQT3 mutant IK1
Further simulations were performed using an idealised area of 2D tissue to investigate the
functional impacts of the SQT3 mutations on the dynamic behaviours of re-entrant excitation
waves, including the lifespan, stability and meandering pattern of the re-entry (see S5 and S6
Figs). In the WT condition, re-entrant waves had an average lifespan of<300 ms, as the tip of
the re-entry consistently meandered out of the tissue boundaries. As for the WT-D172N muta-
tion condition, re-entry sustained (lasted for the 5.0 s duration of the simulation) in 3/5 simu-
lations, with spiral waves drifting unpredictably and following relatively linear trajectories (see
S5 Fig) [32]. In the homozygous D172N mutation condition, sustained re-entry occurred in
5/5 simulations. When the S2 stimulus was applied early after the ERP, the emergent spiral
wave interacted with the refractory tail causing transient wave break and meander, before set-
tling into a stationary, tightly-clustered hyper-meandering trajectory [32].
In the WT-E299V condition, re-entry sustained in 5/5 simulations. However, this mutation
condition was the most prone to wave break, due to drift-induced differences in refractoriness
across the 2D tissue patch and a high frequency of rotation. The homozygous E299V mutation
produced sustained re-entry in 3/5 simulations. This mutation produced spiral waves which
rotated with a slower dominant frequency (DF) than the heterozygous form of the mutation
(see S3 Table). Spiral wave trajectories in the E299V condition drifted significantly and showed
distinctive ‘outward petals’, also known as a hypocycloidal meander pattern [32].
The temporal evolution of spiral wave core trajectories in 2D tissue is shown in S5 Fig for all
mutation conditions and the average lifespan of spiral waves and area of meander in time are
summarised in S6 Fig. Whereas both the D172N and WT-E299V mutation conditions sustained
in all simulations, spiral waves in the WT-E299V condition meandered over a much larger area
on average (representative simulations shown in S1–S5 Videos). The average lifespan of spiral
waves in the homozygous E299V mutation condition was shorter than in the heterozygous con-
dition due to increased tissue excitability, which led to a more unstable form of re-entry.
Arrhythmia simulations in the 3D virtual human atria
The results of 3D simulations, where re-entrant scroll waves were initiated using the phase dis-
tribution method, are summarised in Fig 6. Re-entrant excitation waves sustained for ~3.3 s in
Atrial proarrhythmia in short QT syndrome 3
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the WT condition, before self-terminating (S6 Video). In the heterozygous and homozygous
D172N mutation conditions, re-entrant scroll waves were sustained for the 5.0 s duration of
the simulation, with co-existence of multiple wavelets in the homozygous D172N mutation
condition (S7 and S8 Videos). In the WT-E299V mutation condition re-entry was also sus-
tained for the duration of the simulation, though scroll waves meandered significantly for ~2.0
Fig 6. Scroll waves and corresponding APs in 3D virtual human atria. Evolution of scroll waves following initiation of re-entry,
from time t = 1000 ms (i) to t = 3000 ms (ii) to t = 5000 ms (iii) in WT (A), WT-D172N (B), D172N (C), WT-E299V (D), and E299V
(E) conditions, with corresponding APs extracted from the RA (recording location is marked with an asterisk in panel Ai) (iv). The
viewpoint is looking at the RA posterior wall.
https://doi.org/10.1371/journal.pcbi.1005593.g006
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s before settling into a stable, anatomical re-entry around the opening of the inferior vena cava
(S9 Video). In the homozygous E299V condition, the initiated scroll wave meandered over a
large area, before ultimately colliding with its own refractory tail and self-terminating at ~2.4 s
(S10 Video). The DF and lifespan of re-entry, where applicable, are summarised in Table 2. It
should be noted that while SQT3 mutation conditions favoured development of sustained re-
entry, the resulting patterns were relatively organized and did not cause chaotic fibrillatory
behaviour as seen in atrial fibrillation.
‘Pharmacological’ investigations in the 3D virtual human atria
The effects of all drug interactions simulated on APD prolongation and dispersion (ΔAPD) at
1 Hz are summarised in S7 Fig. All reductions to potassium channel conductances investigated
in the WT-D172N condition prolonged the APD to some extent, whilst also restoring ΔAPD
to roughly the same level seen in the WT condition (see S8 Fig). Agonism of the L-type calcium
channel prolonged APD, however, it also resulted in a significant increase in ΔAPD. In the
WT-E299V condition, inhibition of potassium channels prolonged the APD but only caused a
modest increase in ΔAPD. Individual or combined channel blocks involving IK1 resulted in
incomplete excitation of the PV region. A 100% increase in ICaL was effective in prolonging
APD and restoring ΔAPD; however, excessive agonism of the L-type calcium channel (such as
250% in our simulations) was shown to hugely increase ΔAPD beyond the WT level, similar to
the situation observed in the WT-D172N mutation condition.
Snapshots of simulated pharmacological modulation of re-entry in WT-D172N and WT-
E299V conditions are shown in Fig 7, with corresponding localised atrial excitations extracted
from the RA. 50% individual reductions of IK1 and IKr alone were insufficient to terminate re-
entry in the WT-D172N condition; although both caused a decrease in the DF (IK1 block pro-
duced a more significant decrease in DF–Table 3). However, combined 50% block of IK1 and
IKr resulted in self-termination of the re-entrant wave after ~3.1 s, as shown in Fig 7. A 50%
reduction in the atrial-specific IKur exhibited only a very mild anti-arrhythmic effect, reducing
the DF from 5.2 Hz to 5.0 Hz but failing to terminate re-entry. When this was paired with a
50% reduction in IKr, however, re-entrant excitation waves self-terminated after ~0.5 s (S11
Video).
A 100% increase in ICaL in the WT-D172N condition significantly reduced the DF of re-
entry, from 5.2 Hz to 4.2 Hz, yet was insufficient to terminate re-entrant excitation waves.
Increasing ICaL by 250% resulted in transient re-entrant excitations which self-terminated after
~0.6 s.
The combination of 50% IK1+IKr reduction was successful in preventing sustained re-entry
in the WT-E299V condition, as well as 50% IK1 reduction alone. However, measurements of
the APD dispersion at a normal pacing rate showed that reducing IK1 in the WT-E299V condi-
tion precluded complete excitation of the PV region (S7 Fig). 50% reduction of IKr, on the
other hand, was also sufficient to terminate re-entry (Fig 7) whilst maintaining excitability
across the entire human atria.
Table 2. A summary of dominant frequency and lifespan in 3D simulations.
WT WT-D172N D172N WT-E299V E299V
DF (Hz) N/A 5.2 7.5 5.3 N/A
Lifespan re-entry (s) 3.3 5.0 (sustained) 5.0 (sustained) 5.0 (sustained) 2.4
Dominant frequency (DF) was calculated for all continuous time series of APs.
https://doi.org/10.1371/journal.pcbi.1005593.t002
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As in the WT-D172N condition, 50% reduction of IKur alone in the WT-E299V mutation
condition demonstrated a mild anti-arrhythmic effect, causing a small decrease in DF from 5.3
Hz to 4.8 Hz which, when combined with 50% block of IKr, was sufficient to terminate re-
Fig 7. Simulated drug effects in 3D virtual human atria. Snapshots of simulated drug effects on re-entrant scroll waves in WT-D172N (A) and
WT-E299V (B) conditions. For both mutation conditions panels correspond to the following cases: control (i), 50% IKr block (ii), 50% IK1 block (iii),
combined 50% IK1+IKr block (iv), 50% IKur block (v), combined 50% IKr+IKur block (vi), 100% increase in ICaL (vii), and 250% increase in ICaL (viii). For
each case, two columns are shown which correspond to t = 500 ms and t = 5000 ms after initiation of re-entry, and corresponding APs extracted from
the RA are shown below.
https://doi.org/10.1371/journal.pcbi.1005593.g007
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entry (S12 Video). Simulated calcium channel agonism in the WT-E299V condition also
yielded similar results to the WT-D172N mutation; increasing ICaL by 100% significantly
reduced the DF of re-entry but was insufficient to cause termination of re-entry, whereas a
250% increase in ICaL rapidly terminated re-entry. Summaries of all pharmacological investiga-
tions in the human atria in WT-D172N and WT-E299V conditions are presented in Table 3.
Comparison with an alternative human atria model
Model-specificity of results was investigated by conducting further simulations using the
Grandi et al. (GB) model of the human atrial AP [33]. The GB model was previously employed
by Deo et al. in order to demonstrate human atrial APD shortening, loss of rate-adaptation of
the APD, and increased vulnerability to re-entry in homogeneous tissue associated with the
E299V-Kir2.1 mutation [6]. The APD shortening observed in our study in E299V mutation
conditions using the GB model is consistent with that observed in the study of Deo et al. [6],
and is qualitatively similar with our simulation results using the CZ model (see S10A Fig).
Results with the two models were also similar for the D172N mutation, although this caused a
larger relative degree of APD shortening in the GB model than in the CZ model, as the GB
model AP exhibits a slow repolarisation tail and lack of prominent plateau phase, showing
greater sensitivity to changes in repolarising IK1. Changes to single cell properties such as
APA, RMP, and MUV observed in the GB model mirrored those found in the CZ model (see
S4 Table).
The maximal slope of APD restitution was decreased in all SQT3 mutation conditions com-
pared to the WT, as observed in the CZ model (see S10B Fig). In addition, global dispersion of
APD was decreased more significantly by the E299V mutation than the D172N mutation in
the GB model, reproducing another finding in the CZ model (S11 Fig). These findings are
reassuring; changes to tissue excitability and stability of re-entry in SQT3 mutant IK1 condi-
tions identified in the CZ model were mediated by the RMP, APD, and dispersion of APD–
alterations to all of which were reproduced using an alternative, well-established human atrial
cell model [33].
Discussion
The 3D virtual human atrium is a simulation tool for the clinical study of excitation waves
in the human atria in sinus rhythm and AF [23,34,35], and has been employed in several of
our previous studies [23,34,36]. This study builds on previous in silico work [6,37,38] on
Table 3. A summary of simulated drug effects in the WT-D172N and WT-E299V conditions.
WT-D172N WT-E299V
DF (Hz) Lifespan re-entry (s) DF (Hz) Lifespan re-entry (s)
Control 5.2 5.0 (sustained) 5.3 5.0 (sustained)
+50% IK1 block 4.0 5.0 (sustained) N/A 4.4
+50% IKr block 4.8 5.0 (sustained) N/A 3.6
+50% IK1/IKr block N/A 3.1 N/A 2.5
+50% IKur block 5.0 5.0 (sustained) 4.8 5.0 (sustained)
+50% IKr/IKur block N/A 0.5 N/A 4.5
+100% ICaL 4.2 5.0 (sustained) 4.2 5.0 (sustained)
+250% ICaL N/A 0.6 N/A 1.5
Averaged dominant frequency (DF) and lifespan of re-entry were computed from time series of APs from several locations on the 3D human atria geometry
recorded during re-entry simulations.
https://doi.org/10.1371/journal.pcbi.1005593.t003
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investigating the substrate for AF in potassium channel-linked SQTS by utilising multi-scale
idealised atrial tissue models as well as the 3D virtual human atrium, which incorporates het-
erogeneous atrial electrophysiology in an anatomically-realistic setting [23,34]. This study is
the first to our knowledge to characterise in silico the effects of genetic mutations associated
with any form of the SQTS with inclusion of intrinsic regional differences in cellular electro-
physiology and anatomical details in the human atria. Furthermore, we present a theoretical
exploration of pharmacological interventions for atrial arrhythmias in SQT3, which has poten-
tial clinical relevance.
Main findings
Our major findings are as follows. (1) Heterozygous and homozygous D172N and E299V
mutations shortened the APD through different mechanisms–the D172N mutations through
increased outward IK1 during the terminal phase of repolarisation and the E299V mutations
through increased IK1 at depolarised membrane potentials throughout the AP. (2) SQT3 muta-
tions shortened the wavelength of re-entrant excitation waves through a reduction in both ERP
and CV, which is mediated primarily by effects on the RMP that affects tissue excitability. (3) A
higher degree of APD dispersion was preserved in the D172N mutations than E299V mutations,
with co-existence of short APDs and larger regional APD differences leading to a more stable
form of re-entry. (4) Pharmacological modulation of AF in SQT3 showed some differences
between D172N and E299V mutations. However, combined IKr and IKur block emerged as a
safe pharmacological option in both forms of SQT3 in our simulations.
Pro-arrhythmic effects of SQT3 mutant IK1
Up-regulation of IK1 is an unequivocal finding in ionic remodelling of the human atrial AP
associated with AF [11–14]. Computational studies of human atrial cells have suggested this to
be the primary determinant of APD shortening underlying self-perpetuation of AF [15], as
well as an important determinant of rotor stability and frequency in tissue [16]. An in silico
investigation of the familial AF V93I-Kir2.1 mutation to IK1 by Kharche et al. [17] showed that
both heterozygous and homozygous forms of the mutation (which increased both inward and
outward IK1) shortened APD, hyperpolarised RMP, flattened restitution curves of APD, ERP,
and CV, and stabilised rotors in the 3D virtual human atria. Unlike the present investigation,
however, that study [17] lacked incorporation of heterogeneity of human atrial electrophysiol-
ogy, which has been found to be an intrinsic characteristic of the atria [19–22].
In this study, differences in the IK1 I-V relationship caused by the SQT3 mutations were
investigated, shown in Fig 1, manifesting differences in the way the mutations affected the AP.
The SQT3 proband identified in [4], who was heterozygous for the D172N Kir2.1 mutation,
presented with a history of presyncope and palpitations, which are often caused by supraven-
tricular tachycardias originating in the atria [39]. In our simulations, the D172N mutation
decreased overall ΔAPD by only a small degree in the 3D virtual human atria, whilst preserving
a high degree of heterogeneity at the PV/LA junction, and increasing ΔAPD at the CT/PM
junction (S3 Fig). It has previously been shown that short APDs co-existing with regional
differences in APD creates a substrate favourable to the sustenance of re-entry in human [23]
and canine [24] AF remodelled atria. Our results are consistent with this finding, as both the
heterozygous and homozygous D172N mutation conditions were capable of sustaining re-
entry in the 3D virtual human atria. In our previous study of SQT3 and ventricular repolarisa-
tion, the D172N-Kir2.1 mutations were shown to significantly shorten APD and QT interval
in a computational model of human ventricular myocytes, accelerating and stabilising re-
entrant excitation waves in the human ventricles [40]. As in the present study, electrical
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heterogeneities were shown to play an important role in the arrhythmia substrate, as aug-
mented transmural dispersion of APD at localised regions of the ventricles led to increased
temporal vulnerability to the genesis of uni-directional conduction block and spatial vulnera-
bility to the initiation and sustenance of re-entry.
The E299V mutation differed from the D172N mutation in that it shortened the AP by
increasing outward IK1 throughout the duration of the AP, not just during terminal repolarisa-
tion. In the heterozygous form of the mutation, this manifested itself as a small hyperpolarisa-
tion of the RMP, reduced APA and MUV, and dramatically shortened APD90. These findings
are in qualitative agreement with a recent study which investigated the effects of injecting vir-
tual ‘wild-type’ IK1, ‘loss-of-function’ IK1 associated with Andersen-Tawil syndrome, and
‘gain-of-function’ heterozygous E299V mutant IK1 via dynamic clamp on the action potential
profile of human induced pluripotent stem cell derived cardiomyocytes [41].
The SQT3 proband in [6], who was heterozygous for the E299V-Kir2.1 mutation, presented
with multiple episodes of paroxysmal AF. In our simulations the E299V mutation conditions
significantly reduced APD heterogeneity across the human atria, whilst affecting heterogeneity
at critical junctions differentially. Whereas the profound loss of overall ΔAPD in the pure
E299V condition resulted in only transient re-entrant wave behaviour in 3D simulations, the
intermediate loss of APD heterogeneity combined with abbreviated APD resulted in sustained
re-entry in the WT-E299V condition. Interestingly, in our 2D simulations which were electri-
cally-homogeneous, re-entry sustained in 3/5 simulations in E299V mutant tissue and the area
of meander was comparable to the WT-E299V mutation condition (see S6 Fig), suggesting
APD heterogeneity played an important role in re-entry dynamics in the 3D anatomical atria.
The difference in effects of the homozygous E299V mutant conditions in 2D and 3D simula-
tions underscores the value of conducting simulations at both levels. The long term behaviour
of scroll waves in the 3D virtual human atria was not investigated; it can, however, be specu-
lated that the combination of significant drift and reduced APD heterogeneity decreases the
long-term stability of re-entrant circuits in tissue which increases the likelihood of eventual
self-termination of re-entrant activity, mimicking the paroxysmal AF of the proband in [6].
This is different to the more stable form of re-entry predicted for the D172N mutation condi-
tions (especially homozygous D172N which showed stationary meander patterns–see S5 Fig
and S3 Video).
Not only does a large APD dispersion facilitate the sustenance of re-entrant excitations as
suggested by our simulations, but significant regional differences in APD facilitate the genesis
of re-entrant excitations, as temporal vulnerability of tissue to uni-directional conduction
block is increased. This is consistent with prior experimental evidence that large dispersion of
APD in the atria increases susceptibility to re-entry through local conduction blocks [42,43].
This suggests that large regional differences in ΔAPD associated with the SQT3 mutations
increase the susceptibility to the initiation of re-entrant arrhythmias. This was confirmed in
supplementary simulations by an increase in the temporal window of vulnerability to uni-
directional conduction block at the CT/PM junction associated with all SQT3 mutation condi-
tions, as shown in S4 Fig.
In addition to multiple pro-arrhythmic effects identified in the SQT3 mutations, both the
D172N and E299V mutations were shown to flatten the restitution of APD, which may have a
mixed anti- and pro-arrhythmic effect. Whereas steep restitution slopes facilitate alternans
at the cellular level leading to wave-break in tissue, flattened restitution curves represent a
loss of rate-adaptation, which can facilitate maintenance of high frequency excitation waves
[17,36,44]. In the case of the D172N mutation, this finding is at variance with that reported in
our previous study of human ventricles, in which simulated restitution curves were steepened
[40]. The reason for this difference is not completely clear. It is likely due to differences in the
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models used, as this study used an atrial model and our previous study used a ventricle model
[40]. It is known that there are atrio-ventricular differences in the relative roles of IK1, i.e. IK1
has a much larger current density in the ventricles [2,45], which is likely to affect responses of
the models to ‘gain-in-function’ mutations to IK1. By way of further comparison, in our previ-
ous study of a KCNJ2 mutation associated with familial AF, both the Kir2.1 V93I mutation
which increases outward IK1 and a simple linear increase in maximal conductance of IK1 were
shown to flatten APD and ERP restitution curves [17], consistent with observations in the
present study.
Pharmacological effects on re-entry in 3D virtual human atria
Use of the 3D virtual human atria in this study was extended in order to glean some insight
into potential pharmacological targets in the treatment of SQT3-mediated AF. To date, no spe-
cific blockers of IK1 are in clinical use. In the case of the WT-D172N mutation, combined 50%
reduction of IK1 and IKr was shown to be superior to 50% reduction of either IK1 or IKr alone
in terminating re-entry. Chloroquine, which has been shown to be an effective inhibitor of
D172N mutant Kir2.1 channels [26,46,47], blocks Kir2.1 and hERG channels at overlapping
concentrations [26]. The results of our modelling thus provide evidence that a drug such as
chloroquine, which inhibits both IK1 and IKr, may be effective in treating AF associated with
the D172N mutation. Previous modelling studies have highlighted the potential of chloroquine
to normalize ventricular repolarisation in D172N Kir2.1-linked SQT3 and to terminate rotors
in paroxysmal and chronic AF, which are associated with increased IK1 [47,48]. Our findings
are also consistent with a study by Noujaim et al. [49], in which chloroquine was shown to suc-
cessfully terminate re-entry associated with up-regulated Kir2.1.
In the case of the WT-E299V mutation condition, the combination of 50% block of IK1 and
IKr was effective in preventing sustained re-entry, suggesting that an agent combining these
actions may also be effective in this form of SQT3. However, IK1 block in the WT-E299V con-
dition, either alone or combined with IKr block, was also shown to cause incomplete excitation
of the pulmonary vein region at a normal pacing rate. This could potentially result in further
abnormalities of conduction or provide a re-entrant circuit for excitation waves around the
partially inexcitable pulmonary veins, suggesting IK1 blockers may be unsuitable for manage-
ment of AF mediated by the E299V-Kir2.1 mutation.
A 50% reduction in IKr alone was also sufficient to terminate re-entry in the WT-E299V
mutation condition. At the single-cell level 50% IKr block had a relatively modest effect on the
baseline APD (S7 Fig). This finding could, therefore, be a consequence of the inherently unsta-
ble nature of re-entry associated with the WT-E299V mutation, which is associated with par-
oxysms of AF [6]. Measurement of APD dispersion at 1 Hz (S7 Fig) revealed that the PV
region was affected quite significantly by blocking IKr (this region has higher expression of IKr
[20,21]), potentially de-stabilising circuits around this region. Again, this highlights the useful-
ness of conducting multi-scale simulations, as changes to the APD at the single cell level may
not necessarily be a good predictor of drug effects in electrically-heterogeneous, realistic geom-
etries [24]. Notably, the SQT3 proband in [6] was given amiodarone, which exerts its class III
anti-arrhythmic action predominantly through block of IKr [50], to effectively control AF.
Whereas a selective reduction in IKur was unable to terminate re-entrant excitation waves,
combined block of IKr and IKur was shown to be effective in terminating re-entry in both
WT-D172N and WT-E299V mutation conditions. Combined inhibition of IKr and IKur has
previously been shown to cause a synergistic increase in APD in a mathematical model of AF-
remodelled human atrial cells [51]. As IKur is not expressed in ventricles, this combination
would be expected to exert a greater APD prolongation in the atria, making it more of an
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atrial-specific preventative measure against AF, which was the primary clinical presentation of
the proband identified in [6].
Deo et al. [6], who first identified the E299V mutation in KCNJ2, suggested that an ICaL
activator of the BayK 8644 type may have some therapeutic value in this form of SQT3. We
tested this hypothesis in the 3D virtual human atria by increasing maximal conductance of
ICaL. A 100% increase in ICaL significantly reduced the DF of re-entrant AP waveforms, from
5.3 Hz to 4.2 Hz in the WT-E299V condition. A 200% increase in ICaL further reduced the DF
to 3.8 Hz, yet was still insufficient to terminate re-entrant wave behaviour. We found that the
increase in maximal ICaL conductance necessary to terminate re-entry in the WT-E299V con-
dition (250% in our simulations) significantly depolarised the RMP, reduced MUV, and signif-
icantly increased global APD dispersion in the human atria (S8 Fig). Deo et al. reported that
increasing ICaL to the level necessary to restore the APD produced unphysiologically large cal-
cium transients in a model of human ventricular myocytes [6], which is likely to significantly
increase hypertensive risk. Furthermore, such a large increase in inward calcium currents
could promote a torsadogenic effect in the ventricles. Effects of simulated ICaL agonists in the
WT-D172N condition were qualitatively similar to those obtained in the WT-E299V mutation
condition in that a high degree of ICaL agonism demonstrated anti-arrhythmic effects but pro-
foundly increased dispersion of APD across the human atria. Our simulations thus provide
further evidence that ICaL agonists may be undesirable therapeutic candidates for AF mediated
by both forms of SQT3 investigated.
Limitations
Limitations of the CZ model and 3D virtual human atria, such as the validation of regional cell
models using primarily canine data and lack of a complete tissue fibre structure, have been dis-
cussed in detail elsewhere [23,34]. This study aimed to investigate arrhythmia substrates aris-
ing from purely cellular electrophysiological differences in SQT3 KCNJ2 mutations, and as
such did not consider effects of electrical or intracellular gap junction remodelling or fibrosis.
Evidence of electrical and structural remodelling in SQT3 patients is currently lacking; never-
theless, these factors may contribute to the arrhythmia substrate [23,52] and give rise to multi-
ple wavelets characteristic of AF. A further limitation may come from the fact that cardiac
mechanical contraction was not considered, which, for ventricular function at least, has previ-
ously been suggested to be affected in SQTS patients [53–55], and may affect re-entrant wave
dynamics [56,57].
The IK1 formulations in this study are based on current recordings from Kir2.1 channels.
The WT IK1 formulation recapitulated the most salient difference between human atrial and
ventricular IK1, i.e. the vastly reduced maximal current density [2,45] (compared with our pre-
vious study in human ventricles [40]), whilst retaining a high degree of similarity in kinetics
with leading human atria models [30,33,58] (see S12 Fig). Native IK1 is carried by homo- or
heteromeric assemblies of each of the Kir2.x (Kir2.1, Kir2.2, Kir2.3) subunits expressed in car-
diac myocytes [59]. Human atrial IK1 has been reported to show weaker rectification than its
ventricular counterpart [45], suggesting the possibility of a more prominent than in ventricle
role for the Kir2.3 isoform [59]. However, whereas the Kir2.3 protein has been shown to be
more abundant in human atrium than ventricle (10% versus<1%), the Kir2.1 protein was nev-
ertheless measured to have the highest relative abundance amongst Kir2.x isoforms in human
atrium (81% versus 92% in ventricle) [2]. Interestingly, a recent study found that altering the
I-V profile of IK1 to resemble Kir2.3 in mathematical tissue models of the human atrial PV/LA
junction did not affect the role that IK1 played in determining gradients of sodium availability,
MDP, and MUV [60] which dictate drift direction; this suggests that any alteration to re-entry
Atrial proarrhythmia in short QT syndrome 3
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1005593 June 13, 2017 17 / 29
dynamics by incorporation of a Kir2.3-like component would be minimal, and thus unlikely
to change the fundamental conclusions drawn in our study.
Conclusions
The findings of this study add to the growing weight of evidence implicating increased IK1 in
increased susceptibility to the initiation and maintenance of AF, and further highlight the
influence of regional heterogeneities in overall response to gain-of-function mutations that
increase IK1. Functional differences exist between the effects of SQT3-related D172N and
E299V mutations to IK1 on human atrial electrophysiology: distinct mechanisms of APD
shortening between D172N and E299V mutants at the single cell level manifested themselves
as differences in how the mutations affected APD dispersion in the human atria and influ-
enced re-entry dynamics. Heterozygous and homozygous forms of the D172N mutation
resulted in co-existence of short APDs with marked regional heterogeneities which facilitated
maintenance of re-entrant excitation waves in the human atria. In contrast, the E299V muta-
tion presented with more unstable re-entrant wave behaviour due to significantly reduced
global APD dispersion. Combined reduction of IK1 and IKr, mimicking the effects of chloro-
quine, was established as an effective inhibitor of WT-D172N mutant IK1 in 3D re-entry simu-
lations, whereas class III anti-arrhythmic agents which block IKr may offer a safer alternative
to IK1 block in the WT-E299V mutation. In both SQT3 mutation conditions, IKr and IKur
block combined synergistically to increase APD and terminate re-entrant wave behaviour.
Methods
IK1 and human atrial cell models
A contemporary human atrial cell model developed by Colman et al. [23] (CZ model) was
used for the simulations in this study. The original equations for IK1 in the CZ model are native
to the parent Courtemanche-Ramirez-Nattel (CRN) model [58]. In this study, a WT formula-
tion of IK1 was developed based on WT IKir2.1 currents recorded in Chinese Hamster Ovary
cells at physiological temperature [26], and the maximal conductance chosen in order to give
AP characteristics such as APD and RMP within the experimental range measured for human
atrial myocytes (S1A Fig). IK1 formulations for heterozygous (WT-D172N) and homozygous
(D172N) SQT3 mutants were also developed based on fitting voltage clamp data from [26],
and validated using AP clamp data [26]. The waveform used, which is the same as in [26], had
small step-changes in the voltage during late repolarisation, which was reflected in both the
experimental and simulated AP clamp current traces at corresponding time points. Data from
[6] (kindly provided by Deo et al.) were used to describe homozygous E299V and heterozy-
gous WT-E299V mutant channels. The Nelder-Mead simplex algorithm [61] was used to min-
imise the least-squared difference between simulated and experimental I-V relationship data
for all mutation conditions. Simulated I-V relationships (and AP clamp data [26] for the
D172N mutation) are shown in Fig 1, as well as the gK1-V relationship computed from the
same data. Details of model equations are given in Supporting S1 Text (S1 Table).
APD restitution
Restitution of the steady-state APD at 90% repolarisation (APD90) was recorded in a single cell
model, with multiple conditioning stimuli (of amplitude 20 pA/pF and duration 2.0 ms)
employed until a stable solution was reached. A standard S1-S2 protocol was used in order to
calculate the restitution of the APD against DI, details of which can be found in Supporting S1
Text. The maximal slope of restitution was calculated as the maximum ΔAPD/ΔDI.
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Tissue simulations
Propagation of APs in tissue was described using the monodomain equation [62],
@V
@t
¼ r  D rVð Þ  
ðIion þ IstimÞ
Cm
; ð1Þ
where V is the transmembrane voltage,D is the diffusion coefficient tensor, Iion is the total
ionic current, Istim is an externally-applied stimulus current used to initiate APs, and Cm is the
membrane capacitance. Eq (1) was discretised in space using a central differences finite differ-
ence method as used in previous modelling studies [23,34,63], and integrated at each time step
using a combination of the Rush-Larsen method [64] for gating variables and the forward
Euler method for the cellular membrane potential. In tissue simulations, D was set to 0.21
mm2ms−1 with a 9-fold increase along the fibre direction [23,34,63] in order to give values of
AT and CV consistent with experimental measurements [28,29].
In multicellular tissue simulations where sustained re-entry was initiated, a power spectrum
was obtained through Fourier transform analysis of time series of APs recorded from tissue.
The DF was computed using Matlab based on the largest peak in the power spectrum density.
This simple approach to computing the DF, which has been described in our previous studies
[17,23], is different from the more commonly used definition (e.g. see Ng et al. [65]).
Tissue restitution properties
Tissue restitution properties for WT and SQT3 mutant IK1 channels were determined using a
1D strand model with spatial step 0.25 mm and length 25 mm. After being paced until a stable
solution was reached in a single cell environment, the 1D strand was paced using these initial
conditions from one end with five consecutive conditioning S1 stimuli of spatial size 2.5 mm
before application of an S2 stimulus and subsequent analysis of the final two APs (to account
for APD alternans [66]). Using this protocol, restitution curves for the CV, ERP, and re-entry
WL were computed.
The ERP was defined as the minimal S1-S2 coupling required to elicit an AP which propa-
gated at least three-quarters (about 16.25 mm) of the distance down the strand. The CV was
determined by dividing the distance of the centre section of the strand (measured at nodes one
and three quarters along the strand) by the difference in activation times. WL was computed
using WL = CV × ERP. The excitation threshold, a measure of atrial tissue excitability, in each
of the WT/mutant cases was determined as described previously [17,40]. Briefly, the 1D strand
model was paced using a standard S1-S2 protocol for five beats, following which a stimulus of
constant duration but variable amplitude was applied, and the minimum amplitude required
to elicit an AP which propagated for a given S2 was recorded as a measure of tissue excitability.
Re-entry in a 2D sheet
In supplementary simulations, spiral wave dynamics were investigated using an idealised 2D
sheet of isotropic, electrically-homogeneous tissue with dimensions 100 × 100 mm2 and spatial
step 0.25 mm. A cross-field S1-S2 stimulation protocol was used to initiate re-entrant spiral
waves, as in previous modelling studies [17,37]. After being paced until a stable solution was
reached in a single cell environment, the 2D tissue patch was then paced using these initial
conditions from one edge with four consecutive conditioning S1 stimuli before application of
an S2 stimulus of area 50 × 50 mm2 in the lower left quadrant of the patch. The S2 stimulus
was applied at variable times after the ERP, inducing a wave which propagated uni-direction-
ally and subsequently developed into a spiral wave. The cores of spiral waves were tracked
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using the method of locating phase singularities [67], and the lifespan and area of meander
computed as measures of the stability of re-entry.
Simulations in 3D anatomical human atria geometry
In order to characterise the behaviour of re-entrant excitation waves in an anatomically-realis-
tic setting, the 3D virtual human atrium [34], which is based on the visible human dataset [63],
was employed, as in several of our previous modelling studies [23,34,36]. The 3D geometry
was taken to be electrically heterogeneous, as it is segmented into distinct regions of the atria,
described fully in [23] and shown in Fig 2. The CZ model incorporates a family of regional cell
models, accounting for distinct electrophysiological differences in the right atrium (RA), left
atrium (LA), right atrial appendage (RAA), left atrial appendage (LAA), crista terminalis (CT),
pectinate muscles (PM), atrio-ventricular ring (AVR), atrial septum (AS), Bachmann’s bundle
(BB), and pulmonary veins (PV). Details are provided in Supporting S1 Text, along with S1B
Fig which shows model validation of regional cell models, and S2 Fig which gives a detailed
validation of the PV model. In addition, a degree of fibre anisotropy along the bundles of the
CT, PM, and BB is included. Re-entry was initiated using the phase distribution method [68],
whereby an artificial asymmetric conduction pattern is created, leading to the development of
a 3D spiral (scroll) wave (see S9 Fig and Supporting S1 Text for details). Where applicable,
averaged DF and lifespan of re-entry were calculated based on time series of APs taken from
several locations on the human atria geometry.
Investigating ion channel targets in SQT3-mediated AF
In order to investigate potential pharmaceutical strategies in SQT3-induced AF consequent to
abbreviated APD, effects of prolonging APD via modulating variant ion channels on atrial
excitation were investigated. This was done by either inhibiting potassium channel currents or
augmenting the L-type calcium channel current that prolongs the repolarising phase of the cel-
lular AP. Seeing that SQTS mutations are expressed heterozygously in vivo, we only investi-
gated pharmacological modulation of the WT-D172N and WT-E299V mutants–inhibiting
potassium channel currents (namely IK1, IKr, and IKur) by decreasing their maximal channel
conductance (as done in previous studies [24,50,69]) or increasing ICaL (mimicking the effects
of a calcium channel agonist [70]). As multichannel agents may show superiority in anti-
arrhythmic effects over single channel modulators [71–74], combined single and multiple ion
channel blockers were screened, evaluating their actions first on tissue APD dispersion in the
3D virtual human atria, and then on the dynamic behaviours of re-entrant excitation waves
initiated by the phase distribution method [68] in the 3D model. In these simulations, the DF
and lifespan of re-entry were calculated, where applicable, as indicators of the efficacy of ion
channel block combinations.
Comparison with an alternative human atria model
To draw model independent conclusions, comparative simulations were also performed using
the GB model of the human atrial AP [33] as used in [6], with simplifications to Ca2+ handling
described in [75]. The model is mostly derived from human ventricular data [76], and thus
exhibits different properties to the CZ model. The GB has a type 3 AP morphology [77], com-
pared to the type 1 AP morphology of the model used in the present study. The aforemen-
tioned newly-developed formulations of WT and SQT3 mutant IK1 were incorporated into the
GB model, and the conductances scaled as in the CZ model. Any additional changes to the
baseline model are detailed in Supporting S1 Text.
Atrial proarrhythmia in short QT syndrome 3
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1005593 June 13, 2017 20 / 29
Supporting information
S1 Text. Detailed information on development of simulation tools and supplementary
investigations.
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S1 Fig. Comparison of baseline and regional cell model APs with experimental data. (Ai) A
comparison of the baseline right atrium (RA) model AP used in this study with experimental
recordings of action potentials taken from human RA myocytes (Bosch et al., 1999; Wang
et al., 1993; Wettwer et al., 2004; Koumi et al., 1995; Workman et al., 2001). (Aii) Validation of
baseline model against experimentally-measured metrics; action potential amplitude (APA),
maximum upstroke velocity (MUV), action potential duration at 50% and 90% (APD50 and
APD90, respectively), and resting membrane potential (RMP), using data from Gong et al.,
2008; Poulet et al., 2015; Hordof et al., 1976; Gelband et al., 1972; Pau et al., 2007; Redpath
et al., 2006; Katoh et al., 2005; Bosch et al., 1999; Dobrev & Ravens, 2003; Kim et al., 2002). (Bi)
Regional cell model action potentials from the crista terminalis (CT), right atrial appendage
(RAA), atrio-ventricular ring (AVR), atrial septum (AS), Bachmann’s bundle (BB), left atrium
(LA), pectinate muscles (PM), and RA. (Bii) Comparison of APD90 ratios (APD95 for Feng
et al., 1998) in regional cell models using experimental data from Gong et al., 2008; Katoh
et al., 2005; Feng et al., 1998; Burashnikov et al., 2004; Li et al., 2001.
(DOCX)
S2 Fig. Validation of the pulmonary vein model. (A) A comparison of model changes in
maximal ionic conductances of Ito, IKs, IKr, IK1, and ICaL between PV and LA models against
experimental measurements. (B) Comparison of AP characteristics, namely APD90, MUV, and
APA, between PV and LA models against experimental data. (C) Action potentials from the
LA and PV models at a pacing frequency of 2 Hz compared with experimentally-recorded APs
from canine atrial myocytes (Cha et al., 2005) shown inset. (D) Comparison of difference in
RMP between LA and PV models against experimental measurements. All experimental data
are taken from Ehrlich et al., 2003; Datino et al., 2010; Cha et al., 2005).
(DOCX)
S3 Fig. Differences in regional cell model tissue APD. ΔAPD at the CT/PM and PV/LA junc-
tions as determined in 1D tissue models.
(DOCX)
S4 Fig. Temporal vulnerability window to uni-directional conduction block. Space-time
plots of AP propagation in 1D models of the CT/PM junction used to compute temporal vul-
nerability to re-entry and corresponding vulnerability window (VW) widths. Three scenarios
are shown which correspond to different S2 timings: bi-directional conduction block (A), uni-
directional conduction (B), and bi-directional conduction (C). A summary of VW measure-
ments in WT and SQT3 mutation conditions (D).
(DOCX)
S5 Fig. Re-entry simulations in idealised 2D sheet. A summary of rotor trajectories in 2D re-
entry simulations for different S2 timings after the effective refractory period (ERP).
(DOCX)
S6 Fig. Spiral wave characteristics in 2D re-entry simulations. (A) Bar charts showing the
average lifespan of re-entrant excitations in 5 re-entry simulations corresponding to 5 different
S2 timings; and (B) the average area of meander over time.
(DOCX)
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S7 Fig. APD dispersion in 3D geometry under simulated pharmacological modulation
conditions. (A) WT ΔAPD is shown for reference. ΔAPD in WT-D172N (B) and WT-E299V
(C) tissue is shown under the following conditions: (i) control, (ii) 50% IKr block, (iii) 50% IK1
block, (iv) 50% IK1+IKr block, (v) 50% IKur block, (vi) 50% IKr+IKur block, (vii) 100% increase
in ICaL, and (viii) 250% increase in ICaL. The colour bar shows APD relative to the shortest
APD measured in each condition, designated APD+. The scale of the colour bar is fixed at the
value of ΔAPD in the WT condition (120 ms). Regions where APs failed to exceed −20 mV are
shown in black. Single cell AP traces at 1 Hz pacing are shown in WT-D172N (Di, Dii) and
WT-E299V (Diii, Div) conditions.
(DOCX)
S8 Fig. Summary of ΔAPD and relative APD prolongation in pharmacological simulation
conditions. Floating bar charts showing ΔAPD in WT-D172N (A) and WT-E299V (B) mutant
tissue under various simulated drug effect conditions. The WT ΔAPD is shown in light blue
for reference.
(DOCX)
S9 Fig. Illustration of the phase distribution method and evolution of scroll waves. (A)
Mapping of the membrane potential from an action potential onto the realistic 3D human
atria geometry. (B) Evolution of scroll waves in the RA at different time points using phase dis-
tribution method initial conditions.
(DOCX)
S10 Fig. AP and IK1 profile in WT and mutation conditions using the GB model. Action
potential waveforms in WT, WT-D172N, D172N, WT-E299V, and E299V conditions at a pac-
ing frequency of 1 Hz (Ai), with corresponding current trace for IK1 (Aii). Restitution of the
APD90 (Bi), and maximal slope of restitution (Bii).
(DOCX)
S11 Fig. Regional cell models and spatial dispersion of APD in GB model. Regional cell
models in the GB model (A), including PM, RAA, CT, BB, AS, LA, LAA, AVR, PV. APD dis-
tribution maps in WT (Bi), WT-D172N (Bii), D172N (Biii), WT-E299V (Biv), and E299V (Bv)
mutation conditions, with corresponding ΔAPD (C). The colour bar shows APD relative to
the shortest APD measured in each condition, designated APD+. The scale of the colour bar is
fixed at the value of ΔAPD in the WT condition (72 ms). The colour black shows regions
where membrane potentials failed to exceed a threshold value (−20 mV).
(DOCX)
S12 Fig. Comparison of IK1 kinetics with previous studies. (A) Simulated I-V relationships
for the WT IK1 formulation used in the human atrial cell model in the present study compared
with the WT IK1 formulation used in our previous study in human ventricular cells (Adeniran
et al., 2012)–the inset shows native IK1 recordings in human atrial and ventricular myocytes
taken from Wang et al., 1998. (B) Simulated I-V relationships for IK1 used in this study com-
pared with IK1 from the GPB model (Grandi et al., 2011), CRN model (Courtemanche et al.,
1998), and the NFG model (Nygren et al., 1998).
(DOCX)
S1 Table. IK1 formulation parameters. Parameters of IK1 for WT, WT-D172N, D172N,
WT-E299V, and E299V mutation conditions, obtained by fitting Equation S1 to experimental
data (El Harchi et al., 2009; Deo et al., 2013). For comparison, formulations of the WT model
used in Kharche et al., 2008; and the CRN model IK1 (Courtemanche et al., 1998) are shown.
(DOCX)
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S2 Table. Ionic differences in regional cell models. A summary of conductance scaling fac-
tors, GX, for maximal conductance of ionic current IX relative to the baseline (RA) cell model
and corresponding experimental data sources. Abbreviations are as follows: CT = crista termi-
nalis, BB = Bachmann’s bundle, PM = pectinate muscles, AVR = atrio-ventricular ring,
RAA = right atrial appendage, AS = atrial septum, LA = left atrium, LAA = left atrial append-
age, PV = pulmonary veins.
(DOCX)
S3 Table. Dominant frequency in 2D re-entry simulations. A summary of dominant fre-
quencies (DF) in SQT3 mutation conditions in a representative 2D spiral wave re-entry simu-
lation.
(DOCX)
S4 Table. AP properties in WT and SQT3 mutant conditions in the GB model. A summary
of AP properties such as action potential amplitude (APA), resting membrane potential
(RMP), action potential duration at 50% and 90% repolarisation (APD50 and APD90, respec-
tively), and maximum upstroke velocity (MUV) in the GB model in WT and SQT3 mutation
conditions at a pacing frequency of 1 Hz.
(DOCX)
S1 Video. WT re-entry in 2D idealised geometry. A representative video of initiation and
conduction of spiral waves in a 2D idealised geometry in the WT condition. Re-entry was
induced using an S1-S2 protocol: following propagation of a planar wave elicited with four
conditioning S1 stimuli at a BCL of 400 ms, an S2 stimulus was applied 40 ms after the effective
refractory period in the lower left quadrant of the patch. The initiated spiral wave meanders
out of the tissue boundaries in<200 ms. The evolution of spiral wave core trajectories (marked
by white circles) is superimposed onto the video.
(AVI)
S2 Video. WT-D172N re-entry in 2D idealised geometry. A representative video of initiation
and conduction of spiral waves in a 2D idealised geometry in the WT-D172N condition. Re-
entry was induced using an S1-S2 protocol: following propagation of a planar wave elicited
with four conditioning S1 stimuli at a BCL of 400 ms, an S2 stimulus was applied 40 ms after
the effective refractory period in the lower left quadrant of the patch. The initiated spiral wave
persists for the duration of the simulation. The evolution of spiral wave core trajectories
(marked by white circles) is superimposed onto the video.
(AVI)
S3 Video. D172N re-entry in 2D idealised geometry. A representative video of initiation and
conduction of spiral waves in a 2D idealised geometry in the D172N condition. Re-entry was
induced using an S1-S2 protocol: following propagation of a planar wave elicited with four
conditioning S1 stimuli at a BCL of 400 ms, an S2 stimulus was applied 40 ms after the effective
refractory period in the lower left quadrant of the patch. The initiated spiral wave persists for
the duration of the simulation. The evolution of spiral wave core trajectories (marked by white
circles) is superimposed onto the video.
(AVI)
S4 Video. WT-E299V re-entry in 2D idealised geometry. A representative video of initiation
and conduction of spiral waves in a 2D idealised geometry in the WT-E299V condition. Re-
entry was induced using an S1-S2 protocol: following propagation of a planar wave elicited
with four conditioning S1 stimuli at a BCL of 400 ms, an S2 stimulus was applied 40 ms after
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the effective refractory period in the lower left quadrant of the patch. The initiated spiral wave
persists for the duration of the simulation. The evolution of spiral wave core trajectories
(marked by white circles) is superimposed onto the video.
(AVI)
S5 Video. E299V re-entry in 2D idealised geometry. A representative video of initiation and
conduction of spiral waves in a 2D idealised geometry in the E299V condition. Re-entry was
induced using an S1-S2 protocol: following propagation of a planar wave elicited with four
conditioning S1 stimuli at a BCL of 400 ms, an S2 stimulus was applied 40 ms after the effective
refractory period in the lower left quadrant of the patch. The initiated spiral wave persists for
>4.0 s before meandering out of the tissue boundary shortly before the end of the simulation.
The evolution of spiral wave core trajectories (marked by white circles) is superimposed onto
the video.
(AVI)
S6 Video. WT re-entry in 3D anatomical human atria geometry. Re-entrant scroll waves in
the WT condition initiated in the 3D human atria shown from two views–looking at the RA
posterior wall (left) and into the cavities (right). A single scroll wave persists for ~3.3 s before
colliding with its own refractory tail and self-terminating.
(AVI)
S7 Video. WT-D172N re-entry in 3D anatomical human atria geometry. Re-entrant scroll
waves in the WT-D172N condition initiated in the 3D human atria shown from two views–
looking at the RA posterior wall (left) and into the cavities (right). A single scroll wave follows
a stable trajectory in the right atrium along the junction of the crista terminalis and pectinate
muscles, persisting for the 5.0 s duration of the simulation.
(AVI)
S8 Video. D172N re-entry in 3D anatomical human atria geometry. Re-entrant scroll waves
in the D172N condition initiated in the 3D human atria shown from two views–looking at the
RA posterior wall (left) and into the cavities (right). The initial scroll wave quickly degenerates
into multiple wavelets, persisting for the 5.0 s duration of the simulation.
(AVI)
S9 Video. WT-E299V re-entry in 3D anatomical human atria geometry. Re-entrant scroll
waves in the WT-E299V condition initiated in the 3D human atria shown from two views–
looking at the RA posterior wall (left) and into the cavities (right). Scroll waves meander signif-
icantly around the right atrial appendage and superior vena caval opening for ~2.0 s, before
settling into a stable, anatomical re-entry around the opening of the inferior vena cava which
persists for the 5.0 s duration of the simulation.
(AVI)
S10 Video. E299V re-entry in 3D anatomical human atria geometry. Re-entrant scroll
waves in the E299V condition initiated in the 3D human atria shown from two views–looking
at the RA posterior wall (left) and into the cavities (right). Scroll waves meander significantly
around the right atrial appendage and right atrium, before self-terminating at ~2.4 s.
(AVI)
S11 Video. WT-D172N +50% IKr/IKur block re-entry in 3D anatomical human atria geome-
try. Re-entrant scroll waves in the WT-D172N +50% IKr/IKur block condition initiated in the
3D human atria shown from two views–looking at the RA posterior wall (left) and into the cav-
ities (right). The initial scroll wave quickly breaks up, de-stabilising the re-entrant circuit and
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resulting in self-termination of scroll waves after ~0.5s.
(AVI)
S12 Video. WT-E299V +50% IKr/IKur block re-entry in 3D anatomical human atria geome-
try. Re-entrant scroll waves in the WT-E299V +50% IKr/IKur block condition initiated in the
3D human atria shown from two views–looking at the RA posterior wall (left) and into the cav-
ities (right). The initial scroll wave breaks into multiple wavelets which persist for ~4.5 s, before
self-terminating.
(AVI)
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